Recent news on Rfviia.

Recombinant Factor for Variceal Bleeding in Patients with Cirrhosis  -  May 21, 2007
HULIQ,..."Subgroup analysis of the two trials of rFVIIa in variceal bleeding are planned in order to identify characteristics of patients, who in the future may

New treatments for brain hemorrhage  -  May 6, 2007
News-Medical.net,Recombinant activated factor VII (rFVIIa) is a drug that slows down bleeding and is approved to treat bleeding in patients with hemophilia.

New Drug Could Help Fight Bleeding Strokes  -  May 3, 2007
Forbes,..."rFVIIa is mentioned as potential new treatment that needs confirmation. The efficacy and safety of this treatment must be established in an ongoing phase

Guidelines Updated for Treatment of Spontaneous Intracerebral ...  -  May 3, 2007
Medscape (subscription)Disorders and Stroke–funded Stroke Trials Directory; these are in addition to the ongoing phase III trial of recombinant activated factor VII (rFVIIa).

Cytheris Names CFO and CMO as Company Boosts Clinical Development ...  -  Apr 2, 2007
PharmaLive.com (press release),Other relevant expertise includes clinical development in biotechnology (rFVIII, rFVIIa in particular) as well as regulatory affairs.

Use of Recombinant Factor VIIa for Hip Surgery in a Patient with ...  -  Feb 1, 2007
Journal of Bone and Joint Surgery (subscription)1 Doses of recombinant factor VIIa (rFVIIa) and laboratory test results in the perioperative period. The international normalized ratio (INR),

Drug to increase survival of patients suffering from severe bleeding  -  Dec 11, 2006
CCNMatthews (press release),When rFVIIa is administered intravenously to patients receiving large amounts of blood transfusion, it has the ability to stop bleeding by binding to tissue

Decreased Bleeding Frequency With Secondary Prophylactic Use Of ...  -  Dec 13, 2006
Medical News Today (press release),Randomized, prospective clinical trial of rFVIIa for secondary prophylaxis in hemophilia patients with inhibitors. Data presented during the 48th Annual

Dealing with uncontrolled bleeding  -  Nov 29, 2006
Hindu,That drug is NovoSeven (Recombinant Factor VIIa or rFVIIa), made by Nodo Norvisk, the Danish parmaceuticals company. It has only been licensed foruse with

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional